Real-World data shows asthma Drug's impact on severe cases
NCT ID NCT05091385
Summary
This study looked at how well the drug mepolizumab worked for people with severe eosinophilic asthma in real-world Polish clinics. Researchers followed 106 patients for one year, checking how often they had asthma attacks and how much steroid medication they needed. The goal was to see if regular mepolizumab injections helped control this difficult form of asthma in everyday practice.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA; EOSINOPHILIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Medical University of Lodz, Dept. of Immunology and Allergy
Lodz, 92-213, Poland
Conditions
Explore the condition pages connected to this study.